Literature DB >> 19062118

Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations.

Johannes C A Dimopoulos1, Veronique De Vos, Daniel Berger, Primoz Petric, Isabelle Dumas, Christian Kirisits, Carey B Shenfield, Christine Haie-Meder, Richard Pötter.   

Abstract

BACKGROUND AND
PURPOSE: To investigate the inter-observer variation of target contouring when using the GYN GEC-ESTRO recommendations for MR image-guided brachytherapy (IGBT) for cervical cancer.
MATERIALS AND METHODS: Nineteen cervical cancer patients, treated by radiotherapy at the Institut Gustave Roussy (IGR) in France (n=9) or at the Medical University of Vienna (AKH) in Austria (n=10) were included in this study. IGBT was used for all patients. Two radiation oncologists, one from IGR and the other from AKH, outlined the target volumes on MRI at the time of brachytherapy according to the GYN GEC-ESTRO recommendations. The absolute, common and encompassing volumes and their conformity indices (CIs) were assessed for the GTV, HR CTV and IR CTV. D90 and D100 for each volume were assessed. Visual evaluation was made to assess the reasons for the most frequent inter-observer differences.
RESULTS: The mean volumes of GTV and HR CTV did not differ significantly between the observers, p>0.05. Significant differences were observed only for the mean volumes of the IR CTV of both centres, p<0.05. CIs ranged from 0.5 to 0.7. DVH-parameter analyses did not reveal any statistical differences, except for the D100 for the GTV at AKH, and the D90 for the IR CTV at IGR, p<0.05. Underlying reasons for inter-observer differences included image contrast adjustment and neglecting to consider anatomical borders.
CONCLUSIONS: The results of this inter-observer study show that the application of the GYN GEC-ESTRO recommendations for IGBT contouring at two different institutions with two different traditions for applicators, CTV assessment, MR image acquisition and dose prescription is feasible, and it produces acceptable inter-observer variability.

Entities:  

Mesh:

Year:  2008        PMID: 19062118     DOI: 10.1016/j.radonc.2008.10.023

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  32 in total

1.  Patterns of care for brachytherapy in Europe: updated results for Spain.

Authors:  Ferran Guedea; José López-Torrecilla; Bradley Londres; Montse Ventura; Pedro Bilbao; Josep M Borràs
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

2.  Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.

Authors:  I Fotina; C Lütgendorf-Caucig; M Stock; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-01-27       Impact factor: 3.621

Review 3.  Recent developments and best practice in brachytherapy treatment planning.

Authors:  C D Lee
Journal:  Br J Radiol       Date:  2014-06-02       Impact factor: 3.039

4.  Volume Delineation in Cervical Cancer With T2 and Diffusion-weighted MRI: Agreement on Volumes Between Observers.

Authors:  Consuelo Rosa; Andrea Delli Pizzi; Antonietta Augurio; Luciana Caravatta; Monica DI Tommaso; Erica Mincuzzi; Sebastiano Cinalli; Raffaella Basilico; Annamaria Porreca; Marta DI Nicola; Domenico Genovesi
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

5.  MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy.

Authors:  M Dolezel; K Odrazka; J Vanasek; T Kohlova; T Kroulik; K Kudelka; D Spitzer; M Mrklovsky; M Tichy; J Zizka; L Jalcova
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

6.  Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting.

Authors:  Clifton D Fuller; Jasper Nijkamp; Joop C Duppen; Coen R N Rasch; Charles R Thomas; Samuel J Wang; Paul Okunieff; William E Jones; Daniel Baseman; Shilpen Patel; Carlo G N Demandante; Anna M Harris; Benjamin D Smith; Alan W Katz; Camille McGann; Jennifer L Harper; Daniel T Chang; Stephen Smalley; David T Marshall; Karyn A Goodman; Niko Papanikolaou; Lisa A Kachnic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-18       Impact factor: 7.038

7.  Deep learning for fully automated tumor segmentation and extraction of magnetic resonance radiomics features in cervical cancer.

Authors:  Yu-Chun Lin; Chia-Hung Lin; Hsin-Ying Lu; Hsin-Ju Chiang; Ho-Kai Wang; Yu-Ting Huang; Shu-Hang Ng; Ji-Hong Hong; Tzu-Chen Yen; Chyong-Huey Lai; Gigin Lin
Journal:  Eur Radiol       Date:  2019-11-11       Impact factor: 5.315

Review 8.  Brachytherapy in cancer cervix: Time to move ahead from point A?

Authors:  Anurita Srivastava; Niloy Ranjan Datta
Journal:  World J Clin Oncol       Date:  2014-10-10

9.  Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.

Authors:  Akila N Viswanathan; Beth Erickson; David K Gaffney; Sushil Beriwal; Sudershan K Bhatia; Omer Lee Burnett; David P D'Souza; Nikhilesh Patil; Michael G Haddock; Anuja Jhingran; Ellen L Jones; Charles A Kunos; Larissa J Lee; Lilie L Lin; Nina A Mayr; Ivy Petersen; Primoz Petric; Lorraine Portelance; William Small; Jonathan B Strauss; Kanokpis Townamchai; Aaron H Wolfson; Catheryn M Yashar; Walter Bosch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-01       Impact factor: 7.038

10.  Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.

Authors:  Cem Onal; Gungor Arslan; Erkan Topkan; Berrin Pehlivan; Melek Yavuz; Ezgi Oymak; Aydin Yavuz
Journal:  J Exp Clin Cancer Res       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.